Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021879
Filing Date
2022-11-03
Accepted
2022-11-03 16:14:33
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-20220930.htm   iXBRL 10-Q 3006731
2 EX-31.1 cdak-ex31_1.htm EX-31.1 22965
3 EX-31.2 cdak-ex31_2.htm EX-31.2 23181
4 EX-32.1 cdak-ex32_1.htm EX-32.1 26291
  Complete submission text file 0000950170-22-021879.txt   10831313

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdak-20220930_cal.xml EX-101.CAL 49161
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdak-20220930_pre.xml EX-101.PRE 396829
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdak-20220930.xsd EX-101.SCH 73964
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdak-20220930_def.xml EX-101.DEF 241297
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdak-20220930_lab.xml EX-101.LAB 561804
68 EXTRACTED XBRL INSTANCE DOCUMENT cdak-20220930_htm.xml XML 2162931
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 221358174
SIC: 2836 Biological Products, (No Diagnostic Substances)